Søby, S.; Prestwich, R.; Gyldenkerne, N.; Maare, C.; Lonkvist, C. K.; Andersen, M.; Nowicka-Matus, K.; Gothelf, A.; Tramm, T.; Toustrup, K. Pembrolizumab As First-Line Treatment for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Multi-Institutional DAHANCA Cohort Study. AO 2025, 64, 1269-1275.